Is TherapeuticsMD Inc (TXMD) overvalued? · rev $1.8M
TherapeuticsMD Inc (TXMD) is a drug manufacturers - specialty & generic company listed on US.
This page asks whether TherapeuticsMD Inc (TXMD) looks expensive on cached numbers — not a short thesis.
Latest reported TXMD revenue for 2024-12-31 was $1.8M. Net income was -$2.2M. Revenue was up 35.3% from 2023-12-31 to 2024-12-31. TXMD currently screens at market cap $13.7M.
TXMD currently screens at market cap $13.7M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next TXMD 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the TXMD stock page for the full model, not this heading.
Not investment advice.